Anlitiks Inc.
Kitty Rajagopalan is an experienced leader in health economics and market access, currently serving as Chief Executive Officer and President & Chief Scientific Officer at Anlitiks Inc. since January 2021. Prior to this role, Kitty held the position of Global Head & Vice President, Health Economics & Outcomes Research at Sunovion Pharmaceuticals Inc., where notable achievements included increasing budget allocations from $0 to over $20 million within four years. Kitty also served as Head of Global Health Outcomes, Pricing & Economics at Biogen Idec, focusing on strategic functions and operational frameworks across various therapeutic areas. Kitty holds a PhD and MS in Pharmaceutical Sciences with a specialization in Health Outcomes Research from West Virginia University.
This person is not in any teams
Anlitiks Inc.
Welcome to Anlitiks, a pioneering force at the intersection of technology and science, revolutionizing the way real-world data is transformed into actionable insights. At Anlitiks, our core mission is to empower the life sciences sector by providing swift and efficient analysis of real-world data, turning it into evidence that fosters the development of superior therapeutic solutions and enhances patient health outcomes. Our unique data-agnostic analytic platform-service model, RapidAnalyzer™, is designed to lead the industry in translating complex data into valuable evidence in real-time. We are committed to improving healthcare outcomes through our expertise in real-world evidence generation, market access, and HEOR-related activities. Our consultative approach and dedication to data-driven decision-making enable us to address critical challenges in product development and payment innovation, impacting healthcare globally. Join us on this transformative journey where we redefine the standards of healthcare analytics and contribute to the advancement of patient care and therapeutic development.